Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs VEEE Q2 2025 Earnings Narrower Loss Propels Stock Higher Amid Strategic Transition STRR Q1 2026 Earnings Significant EPS Miss But Stock Gains 342 Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline LIQT Q1 2026 Earnings WiderThanExpected Loss Stirs Caution SERV Q1 2026 Earnings EPS Falls Short of Estimates Amid PreRevenue Phase